NEW
Stock Screener with Intrinsic Value
Novo Nordisk A/S (NVO)
Last Price$86.30.8%
Market Cap$384.7B
26.2%
Industry median - 13.4%
5Y Historical average - 17.2%
41.1%
Industry median - 1.1%
5Y Historical average - 18.5%
(25.4%)
Industry median - (20.2%)
5Y Historical average - 12.2%
(13.4%)
Industry median - (1.2%)
5Y Historical average - 18.4%
NVO Growth Rating
Crunching data... Almost there!
NVO Growth Metrics
Crunching data... Almost there!
Competing with NVO Growth
Overview
Ratings
Intrinsic Value
Valuation
Growth
Profitability
Health
Capital allocation
Momentum
Earnings
Dividends
Crunching data... Almost there!
FAQ
What is the Novo Nordisk A/S (NVO) revenue growth?
The Novo Nordisk A/S (NVO) revenue growth is 26.2%, which is lower than the industry median of 13.4% and the 5-year historical average of 17.2%.
What is the Novo Nordisk A/S (NVO) operating income growth?
The Novo Nordisk A/S (NVO) operating income growth is 41.1%, compared to the industry median of 1.1% and the 5-year historical average of 18.5%.
What is the Novo Nordisk A/S (NVO) EPS (Earnings Per Share) growth?
The Novo Nordisk A/S (NVO) EPS growth is (25.4%), compared to the industry median of (20.2%) and the 5-year historical average of 12.2%.
What is the Novo Nordisk A/S (NVO) Free Cash Flow (FCF) growth?
The Novo Nordisk A/S (NVO) Free Cash Flow growth is (13.4%), compared to the industry median of (1.2%) and the 5-year historical average of 18.4%.